ATE137119T1 - Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen - Google Patents
Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschenInfo
- Publication number
- ATE137119T1 ATE137119T1 AT88908490T AT88908490T ATE137119T1 AT E137119 T1 ATE137119 T1 AT E137119T1 AT 88908490 T AT88908490 T AT 88908490T AT 88908490 T AT88908490 T AT 88908490T AT E137119 T1 ATE137119 T1 AT E137119T1
- Authority
- AT
- Austria
- Prior art keywords
- autoimmune diseases
- human beings
- treating malignant
- conjugated
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1069—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
- A61K51/1033—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants against receptors for cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8570787A | 1987-08-17 | 1987-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE137119T1 true ATE137119T1 (de) | 1996-05-15 |
Family
ID=22193428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88908490T ATE137119T1 (de) | 1987-08-17 | 1988-08-11 | Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050207975A1 (de) |
EP (1) | EP0380542B1 (de) |
JP (1) | JP2581788B2 (de) |
AT (1) | ATE137119T1 (de) |
CA (1) | CA1325591C (de) |
DE (1) | DE3855236D1 (de) |
WO (1) | WO1989001340A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776093A (en) * | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
US5336489A (en) * | 1985-09-05 | 1994-08-09 | The Beth Israel Hospital Association | Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
WO1989006968A1 (en) * | 1988-02-03 | 1989-08-10 | Xoma Corporation | Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
US5276348A (en) * | 1992-06-09 | 1994-01-04 | Advanced Photonix, Inc. | Dot matrix pattern on photosensitive semi-conductor surface |
US5759546A (en) * | 1994-02-04 | 1998-06-02 | Weinberg; Andrew D. | Treatment of CD4 T-cell mediated conditions |
FI95441C (fi) * | 1994-05-31 | 1996-02-12 | Leiras Oy | Inhalointilaitteen lääkeainekammio |
KR100465820B1 (ko) * | 2002-04-16 | 2005-01-13 | 심대근 | 문짝용 플라스틱 판넬 및 그 제조 방법 |
PL217296B1 (pl) | 2002-11-15 | 2014-07-31 | Genmab As | Wyizolowane ludzkie przeciwciało monoklonalne, wytwarzająca je hybrydoma, kodujący to przeciwciało wektor ekspresyjny i zawierająca je kompozycja farmaceutyczna, immunokoniugat, bispecyficzna lub multispecyficzna cząsteczka obejmująca kwasy nukleinowe kodujące ciężki i lekki łańcuch transfektoma, ich zastosowania, zwłaszcza w medycynie, obejmująca te kwasy ex vivo eukariotyczna lub prokariotyczna komórka gospodarza oraz nie będące człowiekiem zwierzę transgeniczne lub roślina, sposób in vitro hamowania wzrostu i/lub proliferacji komórek wyrażających CD25 lub eliminowania komórek wyrażających CD25, sposób wykrywania w próbce obecności antygenu CD25 lub komórki wyrażającej CD25, zestaw diagnostyczny do wykrywania w próbce obecności antygenu CD25 lub komórki wyrażającej CD25 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US903723A (en) * | 1907-12-23 | 1908-11-10 | Nelson Hughes | Buckle. |
SU438419A1 (ru) * | 1968-05-31 | 1974-08-05 | Н. Б. Михеев, М. А. Грачева , А. И. Журба Институт биофизики | Способ получения коллоидного растворас иттрием-90 |
DE2011612C3 (de) * | 1970-03-11 | 1974-03-21 | Institut Medizinskoi Radiologii Amn Ssr, Ussr, Obninsk (Sowjetunion) | Radionuklide enthaltende, resorbierbare Fäden und Filme |
US4709015A (en) * | 1979-12-04 | 1987-11-24 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human suppressor T cells |
US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
US4485093A (en) * | 1982-08-13 | 1984-11-27 | Runge Richard G | Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer |
US4550086A (en) * | 1983-02-16 | 1985-10-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that recognize human T cells |
US4819150A (en) * | 1985-04-05 | 1989-04-04 | Unisys Corporation | Array for simulating computer functions for large computer systems |
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
GB2188941B (en) * | 1986-04-14 | 1990-06-06 | Bayer Ag | Monoclonal antibodies recognizing human interleukin-2-receptor |
FR2616330B1 (fr) * | 1987-06-12 | 1990-12-21 | Immunotech Sa | Agent actif et medicament en contenant destines a prevenir ou a combattre le rejet de greffe d'organe chez l'homme |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
-
1988
- 1988-08-11 DE DE3855236T patent/DE3855236D1/de not_active Expired - Lifetime
- 1988-08-11 WO PCT/US1988/002731 patent/WO1989001340A1/en active IP Right Grant
- 1988-08-11 EP EP88908490A patent/EP0380542B1/de not_active Expired - Lifetime
- 1988-08-11 AT AT88908490T patent/ATE137119T1/de not_active IP Right Cessation
- 1988-08-11 JP JP63507708A patent/JP2581788B2/ja not_active Expired - Lifetime
- 1988-08-17 CA CA000574976A patent/CA1325591C/en not_active Expired - Lifetime
-
2004
- 2004-12-06 US US11/005,575 patent/US20050207975A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050207975A1 (en) | 2005-09-22 |
WO1989001340A1 (en) | 1989-02-23 |
JP2581788B2 (ja) | 1997-02-12 |
EP0380542A4 (en) | 1990-12-05 |
DE3855236D1 (de) | 1996-05-30 |
EP0380542B1 (de) | 1996-04-24 |
CA1325591C (en) | 1993-12-28 |
JPH03500645A (ja) | 1991-02-14 |
EP0380542A1 (de) | 1990-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE190496T1 (de) | Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol | |
DE69533040D1 (de) | Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien | |
DE3485688D1 (de) | Verfahren und vorrichtung zur behandlung von krankheiten. | |
DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
GB2122496A (en) | Method and apparatus for the treatment of autoimmune and allergic diseases | |
MY111961A (en) | Therapeutic method | |
DE3588082D1 (de) | Verfahren und zusammensetzungen zur verwendung in der diagnose und behandlung autoimmuner krankheiten | |
HUT36859A (en) | Tumer-specific monoclinal antibodies | |
EP0069232A3 (en) | Purified antineoplaston fractions and methods of treating neoplastic disease | |
ATE137119T1 (de) | Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen | |
ATE1443T1 (de) | Mittel zur behandlung allergischer reaktionen. | |
JPS57131721A (en) | Drug treatment for body disease | |
DE60042941D1 (de) | Verwendung von anti-cd3 monoklonale antikörper und il-5 zur behandlung von autoimmunkrankheiten | |
NL187299B (nl) | Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten. | |
DE3789958D1 (de) | Verfahren und Apparat zur Bestrahlungsbehandlung, angepasst an das Frequenzspektrum des menschlichen Körpers. | |
EP0642333A4 (de) | Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion. | |
EP0444156A4 (en) | Method for treating vascular diseases | |
IE811612L (en) | Thiazoles | |
DE68902212D1 (de) | Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. | |
GB2126080A (en) | Agent for treating allergic disease immunity complex disease and tumor | |
ATE167398T1 (de) | Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide | |
BE888543A (fr) | Procedes et machines pour le traitement de pierres precieuses, | |
DE3280419D1 (de) | Medizinisches praeparat zur behandlung von hautleiden. | |
SE8306384L (sv) | Farmaceutisk komposition | |
PT75226B (en) | Method for diagnosing and for the therapeutic treatment of tu- mors diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |